The Laboratory  shall report the estimated levels of:  • EtG if ≥ 5 µg/mL;  • Carboxy -finasteride if ≥ 5 ng/mL;  • 4-hydrox y- and/or 6 -hydroxy -dutasteride if ≥ 5 ng/mL;  • Ketoconazole if ≥ 100 ng/mL;        ABP Operating Guidelines  – Version 9.0 – July 2023  Page 52/91 • Fluconazole if ≥ 500 ng/mL;  • Miconazole if ≥ 1,000 ng/mL.